{"nct_id":"NCT01632345","title":"A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2012-10-12","start_date_type":"ACTUAL","primary_completion_date":"2014-12-03","primary_completion_date_type":"ACTUAL","completion_date":"2016-03-21","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}